三倍做多标普生物-Direxion(LABU)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LABU 三倍做多标普生物-Direxion

休市中 07-02 16:00:00 EDT

303.45

+21.28

+7.54%

盘后301.52

-1.93-0.64%

19:59 EDT

最高305.09	最低282.16	成交量52.78万
今开287.59	昨收282.17	日振幅8.13%
总市值7.05亿	流通市值7.05亿	总股本232.45万
成交额1.55亿	换手率22.70%	流通股本232.45万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"三倍做多标普生物-Direxion","latestPrice":303.45,"timestamp":1783022400000,"preClose":282.17,"halted":0,"volume":527772,"hourTrading":{"tag":"盘后","latestPrice":301.52,"preClose":303.45,"latestTime":"19:59 EDT","volume":6878,"amount":2075335.2455,"timestamp":1783036791585,"change":-1.93,"changeRate":-0.00636,"amplitude":0.015258},"delay":0,"changeRate":0.07541552964524921,"floatShares":2324486,"shares":2324486,"eps":0,"marketStatus":"休市中","change":21.28,"latestTime":"07-02 16:00:00 EDT","open":287.59,"high":305.09,"low":282.16,"amount":155277357.0474,"amplitude":0.081263,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1783324800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":282.17,"sharesOutstanding":3024486,"nav":303.542,"aum":705580143.15,"dividendRate":0.0033,"bidAskSpread":0.00316,"preHourTrading":{"tag":"盘前","latestPrice":288.8892,"preClose":282.73,"latestTime":"09:29 EDT","volume":2478,"amount":706505.5536,"timestamp":1782998946691,"change":6.1592,"changeRate":0.021785,"amplitude":0.047324},"postHourTrading":{"tag":"盘后","latestPrice":301.52,"preClose":303.45,"latestTime":"19:59 EDT","volume":6878,"amount":2075335.2455,"timestamp":1783036791585,"change":-1.93,"changeRate":-0.00636,"amplitude":0.015258},"volumeRatio":0.9199150382358624,"impliedVol":0.9931,"impliedVolPercentile":0.8606},"requestUrl":"/m/hq/s/LABU","defaultTab":"news","newsList":[{"id":"2648890691","title":"娃哈哈一茶饮检测出甜蜜素，遭美国FDA“进口警报”，官方暂无回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2648890691","media":"新浪科技","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648890691?lang=zh_cn&edition=full","pubTime":"2026-07-04 22:25","pubTimestamp":1783175100,"startTime":"0","endTime":"0","summary":"7月4日，据报道，美国FDA 近日披露的一份“进口警报”文件显示，娃哈哈集团2026年4月6日生产的一款“红茶及柠檬调味茶”饮料中检测出甜蜜素，并将其类型标注为“DWPE”。只要食品中含有甜蜜素，在FDA眼中就属于“含有不安全食品添加剂”。　　对于上述情况，新浪财经问询了娃哈哈方面，截至发稿前其尚未对该情况作出明确回复。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-07-04/doc-inifscxw9311340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648998976","title":"张琅：健康中国政策的落地进一步释放商业健康保险空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2648998976","media":"金融一线","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648998976?lang=zh_cn&edition=full","pubTime":"2026-07-04 17:50","pubTimestamp":1783158600,"startTime":"0","endTime":"0","summary":"　　谈及未来行业发展机遇，张琅表示，健康中国政策的落地进一步释放商业健康保险空间。　　张琅进一步表示，对于健康险，无论是从健康中国还是投资于人，金融监管总局推动健康保险高质量发展、医保局创新药的放开，都是我们的机会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jryx/insurance/2026-07-04/doc-inifrtka9359402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","XBI","BK4585","XLV","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114431356","title":"医疗保健板块市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1114431356","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114431356?lang=zh_cn&edition=full","pubTime":"2026-07-04 16:21","pubTimestamp":1783153298,"startTime":"0","endTime":"0","summary":"最新医疗保健板块市场动态。益普生股价下跌1.1%。联昌国际证券分析师表示，受4月和5月意外收益的推动，马来西亚手套制造商的股价预计在8月财报季期间将保持相对坚挺。然而，他预计下半年前景将更具挑战性，因为平均销售价格将随着原材料成本下降和持续的行业产能过剩而下滑。随着固定成本居高不下，利润率压力可能会加剧。联昌国际维持对马来西亚手套制造业的中性评级，并将高产柅品工业列为其首选。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","XLV","BK4588","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648695750","title":"云康云科医疗健康科技（广州）有限公司成立","url":"https://stock-news.laohu8.com/highlight/detail?id=2648695750","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648695750?lang=zh_cn&edition=full","pubTime":"2026-07-04 11:33","pubTimestamp":1783135980,"startTime":"0","endTime":"0","summary":"天眼查App显示，近日，云康云科医疗健康科技（广州）有限公司成立，注册资本800万元，经营范围包括健康咨询服务、远程健康管理服务、医学研究和试验发展、人工智能通用应用系统等，由云康健康产业投资股份有限公司全资持股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607043794165922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["VHT","BK4581","LABU","IXJ","XBI","159760","BK4588","BK4550","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190197931","title":"医疗保健板块动态：市场热议聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1190197931","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190197931?lang=zh_cn&edition=full","pubTime":"2026-07-04 04:52","pubTimestamp":1783111925,"startTime":"0","endTime":"0","summary":"0848 ET - 益普生集团本周宣布了两项收购，但其首席商务官菲利普·洛佩斯-费尔南德斯在接受采访时表示，这更像是机缘巧合而非预先计划。这家法国制药商表示，将以高达17.5亿美元的价格收购致力于研发罕见血癌药物的Kartos Therapeutics公司，并在另一项可能超过7亿欧元的交易中，收购专注于肾脏感染治疗的Memo Therapeutics公司。联昌国际集团、国家能源公司、IHH医疗保健集团和金务大公司是其首选股票之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","XLV","BK4581","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138259959","title":"医疗保健板块圆桌：市场热议焦点","url":"https://stock-news.laohu8.com/highlight/detail?id=1138259959","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138259959?lang=zh_cn&edition=full","pubTime":"2026-07-04 00:25","pubTimestamp":1783095922,"startTime":"0","endTime":"0","summary":"医疗保健领域的最新市场对话正在热烈进行。0848 ET - 益普生集团本周宣布了两项收购，但该公司首席商务官菲利普·洛佩斯-费尔南德斯在访谈中表示，这更像是机缘巧合而非精心策划的结果。该股股价下跌1.1%。鉴于对成本压力升级可能削弱消费者和企业信心并导致资产质量恶化的担忧，他们对银行盈利采取了更为保守的立场。联昌国际集团、国家能源、综合保健控股和金务大是他们的首选标的之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","BK4588","BK4581","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648076654","title":"健友股份(603707.SH)子公司获得美国FDA醋酸去氨加压素注射液药品生产场地转移注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2648076654","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648076654?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:34","pubTimestamp":1783067659,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 健友股份(603707.SH)发布公告，公司子公司Meitheal Pharmaceuticals, Inc.(以下简称“Meitheal”)于近日收到美国食品药品监督管理局(以下简称“美国FDA”)签发的醋酸去氨加压素注射液，4mcg/mL 和40mcg/10mL(ANDA号：074888)生产场地转移批准信，批准在公司子公司健进制药有限公司场地生产。本次获批印证公司无菌注射剂生产线及质量体系满足美国cGMP标准，丰富公司北美医疗机构注射剂管线，完善海外自有供应链体系，中长期有望为公司经营业绩带来积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462874.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","LABU","BK0186","BK4588","603707","BK0046","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648654882","title":"健友股份：子公司获美国FDA醋酸去氨加压素注射液生产场地转移批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2648654882","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648654882?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:14","pubTimestamp":1783066453,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648507245","title":"美国劳工统计局：专业和商业服务、社会援助以及医疗保健领域的就业岗位持续增加。休闲和酒店业的就业岗位减少。","url":"https://stock-news.laohu8.com/highlight/detail?id=2648507245","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648507245?lang=zh_cn&edition=full","pubTime":"2026-07-02 20:32","pubTimestamp":1782995569,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","VHT","BK4585","BK4581","BK4588","XLV","BK4550","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648650958","title":"FDA扩大福泰(VRTX)Casgevy基因疗法适用人群 两岁及以上血液病患儿可纳入治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2648650958","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648650958?lang=zh_cn&edition=full","pubTime":"2026-07-02 18:03","pubTimestamp":1782986636,"startTime":"0","endTime":"0","summary":"Casgevy 依托 CRISPR 基因编辑技术改造患者自体造血干细胞，从根源改善血红蛋白缺陷问题，减少患者长期输血与血管闭塞危象发作频次，属于一次性治疗型细胞疗法。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302133","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","LU2237438978.USD","LU2362540622.SGD","IE00B4R5TH58.HKD","LU2456880835.USD","IE0009355771.USD","LU1093756325.SGD","BK4588","LU0320765992.SGD","LU1674673428.USD","LU2236285917.USD","LABU","LU1430594728.SGD","LU0234570918.USD","BK4585","LU2324357040.USD","SG9999001176.SGD","LU2362541513.USD","BK4139","LU1093756168.USD","LU1778281490.HKD","BK4532","IE00B2B36J28.USD","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","LU0109394709.USD","LU0079474960.USD","LU2417539215.USD","LU1585245621.USD","LU2462157665.USD","BK4567","LU2362541273.HKD","LU0417517546.SGD","SGXZ57979304.SGD","LU1069344957.HKD","LU0061475181.USD","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","LU0289739699.SGD","LU0432979614.USD","VRTX","LU0889565916.HKD","IE00B894F039.SGD","BK4533","LU0058720904.USD","SG9999001176.USD","IE00BJJMRZ35.SGD","LU0256863811.USD","IE0002141913.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648529678","title":"美国医疗保险和医疗补助服务中心预估：2027自然年度联邦医保居家护理总支付金额将上调2.4%，新增支出4.2亿美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2648529678","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648529678?lang=zh_cn&edition=full","pubTime":"2026-07-02 04:52","pubTimestamp":1782939136,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4581","XBI","BK4588","BK4585","XLV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648529622","title":"美国医疗保险和医疗补助服务中心提出新增医保参保资格撤销依据，将高风险经营场所纳入其中。","url":"https://stock-news.laohu8.com/highlight/detail?id=2648529622","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648529622?lang=zh_cn&edition=full","pubTime":"2026-07-02 04:52","pubTimestamp":1782939126,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XLV","BK4581","BK4588","BK4585","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648296175","title":"美国医疗保险和医疗补助服务中心发布2027财年家庭健康预付费支付体系拟议规则，每年可节省8200万美元支出并打击欺诈行为","url":"https://stock-news.laohu8.com/highlight/detail?id=2648296175","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648296175?lang=zh_cn&edition=full","pubTime":"2026-07-02 04:51","pubTimestamp":1782939106,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","XBI","XLV","BK4585","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648230575","title":"监管审议前Canaccord上调目标价，Hims & Hers股价应声大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2648230575","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648230575?lang=zh_cn&edition=full","pubTime":"2026-07-02 03:37","pubTimestamp":1782934620,"startTime":"0","endTime":"0","summary":"远程医疗公司Hims & Hers Health股价周三大幅上涨，此前Canaccord Genuity以减肥药业务势头强劲和肽类药物的巨大潜力为由，大幅上调了该股目标价，而美国食品药品监督管理局即将对七种肽类药物进行关键审议。Ripps指出，Hims & Hers持续受益于信用卡消费数据的改善以及品牌减肥药的成功推广。委员会将对七种肽类药物进行审议，此前FDA工作人员建议不允许复方药房生产这些药物，称支持其使用的证据有限且存在尚未解决的安全隐患。　　Hims已提前布局这一潜在机遇。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-02/doc-inifixkn2785036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100965386","title":"医疗保健板块综述：市场热议","url":"https://stock-news.laohu8.com/highlight/detail?id=1100965386","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100965386?lang=zh_cn&edition=full","pubTime":"2026-07-02 00:25","pubTimestamp":1782923108,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场热议。高德美股价下跌5.3%。0318 ET - RBC Capital Markets的Natalia Webster和Charles Weston在一份研究报告中表示，益普生提议收购Memo Therapeutics的交易，最高可能超过7亿欧元，这符合这家法国制药商针对服务不足的罕见病群体的交易策略。分析师指出，该交易通过增加实验性肾脏药物potrivutig，扩展了益普生的罕见病产品组合，该药物可能于2029或2030年上市。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","XBI","LABU","XLV","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648546089","title":"美国医疗保险和医疗补助服务中心扩大 GLP-1 类药物适用报销范围。","url":"https://stock-news.laohu8.com/highlight/detail?id=2648546089","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648546089?lang=zh_cn&edition=full","pubTime":"2026-07-01 21:57","pubTimestamp":1782914261,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","XBI","BK4144","BK4588","GLP","BK4581","BK4590","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199634408","title":"医疗健康板块动态速览：市场热议焦点","url":"https://stock-news.laohu8.com/highlight/detail?id=1199634408","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199634408?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:24","pubTimestamp":1782894251,"startTime":"0","endTime":"0","summary":"最新一期聚焦医疗健康领域的市场对话。该药物预计在2029或2030年左右上市。益普生股价下跌0.1%。市场普遍预期阿斯利康的核心营业利润率将扩大160个基点，但美国银行的分析师更为谨慎，即使其销售额预估高于市场普遍预期。阿斯利康股价下跌0.6%。欧洲斯托克600医疗保健指数上涨0.8%。试验中的负面副作用有限，没有引发新的担忧。在巴黎上市的Abivax股价飙升30%，领涨欧洲斯托克600指数。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","LU0234572021.USD","LU0477156953.USD","BK4559","LU1267930227.SGD","LU1880398554.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","LU1162221912.USD","BK4504","LU1201861165.SGD","LU2265009873.SGD","LU2596442595.SGD","LU2129689514.USD","IE0034235188.USD","IE0002270589.USD","IE00B19Z3581.USD","LU0130102774.USD","BK4585","LU0106831901.USD","LU1280957306.USD","LU0320765489.SGD","LU0170899867.USD","BK4207","LU2133065610.SGD","LU0234570918.USD","LU0053666078.USD","LU0203347892.USD","LU0321505868.SGD","LU1506573853.SGD","LU1035773651.USD","BK4581","BAC","LU1894683264.USD","LU0314106906.USD","IE00BFXG1179.USD","LU0070302665.USD","LU0098860793.USD","LU0787776722.HKD","LU1069347547.HKD","LU1201861249.SGD","LU0256863811.USD","LU1791807156.HKD","LU0477156797.USD","LU1883839398.USD","LU0306806265.USD","LU1366192091.USD","LU1363072403.SGD","IE00B7SZLL34.SGD","LU0052756011.USD","BK4534","IE00BKVL7J92.USD","LU1718418525.SGD","LU0321505439.SGD","LABU","LU2129689431.USD","LU0130103400.USD","LU0648001328.SGD","IE00BZ1G4Q59.USD","LU0417517546.SGD","IE00BLSP4452.SGD","LU0648000940.SGD","LU0211331839.USD","LU1496350502.SGD","IE00B1BXHZ80.USD","LU1074936037.SGD","LU0203345920.USD","BK4588","LU2129689605.HKD","LU0130518102.USD","IE00BBT3K403.USD","LU0683600562.USD","LU0256863902.USD","IE0001KFT4U8.USD","LU1496350171.SGD","LU0868494617.USD","BK4553","LU0306807586.USD","XLV","LU0128525689.USD","LU1668664300.SGD","LU0971096721.USD","LU1880398471.USD","LU0130517989.USD","XBI","LU0149725797.USD","LU0208291251.USD","LU0640476718.USD","LU0980610538.SGD","LU0320765646.SGD","LU0310800965.SGD","LU1804176565.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648518010","title":"津药药业：二丙酸倍他米松原料药取得FDA DMF First Adequate Letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2648518010","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648518010?lang=zh_cn&edition=full","pubTime":"2026-07-01 15:34","pubTimestamp":1782891259,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","DMF","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648599318","title":"FDA批准菲利普莫里斯旗下20款ZYN尼古丁袋产品上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2648599318","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648599318?lang=zh_cn&edition=full","pubTime":"2026-07-01 10:05","pubTimestamp":1782871525,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["ZYN","BK4585","BK4588","IPOS","LABU","LOHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647556191","title":"FDA新组建肽类咨询小组引发行业关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2647556191","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647556191?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:44","pubTimestamp":1782823440,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局近日公布了一个新组建的肽类药物咨询小组的成员名单，其中多名专家与健康诊所和复方药房存在关联，此举引发外界对潜在利益冲突的关注。这些物质在健康领域颇受欢迎，但缺乏充分的人体临床试验证据，且此前因免疫原性、毒性及杂质风险被FDA列入限制名单。　　据报道，这一组成变化体现了推动特定健康议程的努力，此前已有机构重组了CDC疫苗咨询委员会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-30/doc-inifexfu6656081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1771},{"period":"1month","weight":0.9186},{"period":"3month","weight":0.7679},{"period":"6month","weight":0.9267},{"period":"1year","weight":3.9992},{"period":"ytd","weight":0.9038}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.020883},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.009536},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.135885},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.001739},{"month":5,"riseRate":0.545455,"avgChangeRate":0.013816},{"month":6,"riseRate":0.75,"avgChangeRate":0.158596},{"month":7,"riseRate":0.666667,"avgChangeRate":0.053001},{"month":8,"riseRate":0.636364,"avgChangeRate":-0.004065},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.0652},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.047038},{"month":11,"riseRate":0.818182,"avgChangeRate":0.199161},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.032237}],"exchange":"ARCA","name":"三倍做多标普生物-Direxion","nameEN":"Direxion Daily S&P Biotech Bull 3x Shares"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三倍做多标普生物-Direxion(LABU)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三倍做多标普生物-Direxion(LABU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三倍做多标普生物-Direxion,LABU,三倍做多标普生物-Direxion股票,三倍做多标普生物-Direxion股票老虎,三倍做多标普生物-Direxion股票老虎国际,三倍做多标普生物-Direxion行情,三倍做多标普生物-Direxion股票行情,三倍做多标普生物-Direxion股价,三倍做多标普生物-Direxion股市,三倍做多标普生物-Direxion股票价格,三倍做多标普生物-Direxion股票交易,三倍做多标普生物-Direxion股票购买,三倍做多标普生物-Direxion股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三倍做多标普生物-Direxion(LABU)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三倍做多标普生物-Direxion(LABU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}